Company: TVRD
Filing Date: 2025-01-27
Form Type: S-4/A
Source: 0001104659-25-006050
Chunk: 744

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-01-27
Form: S-4/A
Chunk 744
---
70%, which the Company substantially completed by June 30, 2024. As a result, the Company made additional estimates and judgments regarding its future plans, including future employee termination costs to be incurred in conjunction with involuntary separations when such separations are probable and estimable. In the second quarter of 2024, the Company recorded a pre-tax severance expense of $2,581, which was included within restructuring expenses on the Condensed Consolidated Statements of Comprehensive Loss for the nine months ended September 30, 2024. In the third quarter of 2024, the Company recorded an additional pre-tax severance expense of$ 707, which was included within restructuring expenses on the Condensed Consolidated Statements of Comprehensive Loss for the three and nine months ended September 30, 2024. The remaining amounts to be paid as of September 30, 2024 are included within accounts payable and accrued expenses on the Condensed Consolidated Balance Sheet.

The detail of activity related to the Company’s restructuring action is as follows:

| ​                                                                   | ​ | ​ |      ​ |
|:--------------------------------------------------------------------|:--|:--|-------:|
| Total expense recorded in the three months ended March 31, 2024     |   | $ |  2,401 |
| Payments made in the three months ended March 31, 2024              | ​ |   | -1,702 |
| Remaining amounts to be paid as of March 31, 2024                   | ​ | ​ |    699 |
| Total expense recorded in the three months ended June 30, 2024      | ​ | ​ |  2,581 |
| Payments made in the three months ended June 30, 2024               | ​ | ​ |   -301 |
| Remaining amounts to be paid as of June 30, 2024                    | ​ | ​ |  2,979 |
| Total expense recorded in the three months ended September 30, 2024 | ​ | ​ |    707 |
| Payments made in the three months ended September 30, 2024          | ​ | ​ | -3,400 |
| Remaining amounts to be paid as of September 30, 2024               | ​ | $ |    286 |

Leases (Original Corporate Headquarters in 2015 & Amendment for Additional Space in 2020)

Lease expense was recognized on a straight-line basis over the lease term of the Company’s previous lease agreements